LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.
Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S, Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
Matsuda R, et al. Among authors: yoshino h.
Br J Cancer. 2011 Jan 18;104(2):376-86. doi: 10.1038/sj.bjc.6605990. Epub 2010 Nov 9.
Br J Cancer. 2011.
PMID: 21063397
Free PMC article.